Beta
Trial Radar KI

Es werden klinische Studien für Diabetes angezeigt.

Fragen zu Gesundheitszuständen, Behandlungen oder möchten Sie klinische Studien bei Ihnen finden?
Unsere Suchfunktion unterstützt derzeit nur Englisch. Für die Suche und Diskussion in anderen Sprachen verwenden Sie bitte die oben stehende Klinische Studien Radar KI oder wählen Sie unten die Erkrankungs- und Standortfilter aus.
154 Ergebnisse
Zeigt die Top 50
 
Erkrankung
Diabetes
×
 
Stichwörter
Kontinuierliche Glukoseüberwachung
×
 
Geschlecht
Alle
×
 
Phase
Phase 4
×
 
Titel der Studie
Status
The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes. (WARD-glucose) NCT06314061
Offene Rekrutierung
The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus NCT03955107
Unbekannter Status
Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus NCT01016457
Unbekannter Status
Glycemic Holter Study (Continuous Glucose Monitoring) - (OPTIMA) NCT01193296
Abgeschlossen
LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous NCT00322075
Abgeschlossen
Continuous Glucose Monitoring in Patients With Type 2 Diabetes (CGM) NCT00529815
Unbekannter Status
Assessing Continuous Glucose Monitors in Healthy Children NCT00069602
Abgeschlossen
Continuous Glucose Monitors for Children With Diabetes Mellitus NCT00069537
Abgeschlossen
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity NCT06699810
Offene Rekrutierung
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus (TLI vs PMI) NCT06925334
Rekrutierung auf Einladung
Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients NCT02009514
Abgeschlossen
Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement (SAFIR) NCT00354939
Abgeschlossen
Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring (OPTIMAL) NCT04559191
Unbekannter Status
CGM - Reimagine Primary Care NCT04413578
Abgeschlossen
Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus NCT04120623
Unbekannter Status
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients (inRange) NCT04075513
AbgeschlossenErgebnisse veröffentlicht
Effectiveness Study of the Guardian RT in Type 1 Diabetics NCT01331343
Abgeschlossen
Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients (GlyCEDIA) NCT01828970
Abgeschlossen
An Exploratory Study on the Application of Continuous Glucose Monitoring System in the Measurement of Individual Glycemic Index After Eating Different Diets NCT04562454
Unbekannter Status
Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes NCT03226210
Abgeschlossen
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes NCT06127433
Unbekannter Status
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355) NCT02318693
AbgeschlossenErgebnisse veröffentlicht
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment NCT01076842
Abgeschlossen
Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM NCT05677334
Abgeschlossen
Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes NCT04533646
AbgeschlossenErgebnisse veröffentlicht
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management NCT07224893
Noch nicht rekrutierend
Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. (SafrTravlT1D) NCT03668808
AbgeschlossenErgebnisse veröffentlicht
Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day (SeLan) NCT01234597
Abgeschlossen
Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes NCT03107208
AbgeschlossenErgebnisse veröffentlicht
The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus (PLATEAU) NCT04414579
Unbekannter Status
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride NCT00633425
Abgeschlossen
Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump (BIG LEAP) NCT04409587
Abgeschlossen
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus (Soli-CGM) NCT05114590
AbgeschlossenErgebnisse veröffentlicht
Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes? NCT04772729
Unbekannter Status
Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered NCT03838783
Unbekannter Status
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes NCT04893148
Unbekannter Status
The EMPA-FIT Study NCT06846411
Offene Rekrutierung
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion NCT01030952
AbgeschlossenErgebnisse veröffentlicht
An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin (COMETA) NCT03267576
AbgeschlossenErgebnisse veröffentlicht
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer NCT00069628
Abgeschlossen
A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes NCT01730885
Abgeschlossen
Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes (VIDA) NCT01862263
Abgebrochen
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes NCT05904743
Abgeschlossen
Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps. NCT02685449
Unbekannter Status
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2) NCT00530023
AbgeschlossenErgebnisse veröffentlicht
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus (TRACK) NCT02771093
AbgeschlossenErgebnisse veröffentlicht
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey (EASE) NCT02954692
Abgeschlossen
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes (E-SEMPA) NCT06613854
Offene Rekrutierung
Effect of CSII and CGM on Progression of Late Diabetic Complications NCT01454700
Abgeschlossen
Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study) NCT03202563
Abgeschlossen